These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17476913)

  • 1. [New diabetes recommendations can not be uncritically implemented in Swedish primary health care].
    Wajngot A; Tovi J
    Lakartidningen; 2007 Mar 28-Apr 3; 104(13):1063-4. PubMed ID: 17476913
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 3. Implementing treatment guidelines for type 2 diabetes in primary care.
    Brunton S
    Postgrad Med; 2009 Mar; 121(2):125-38. PubMed ID: 19332971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restaging insulin therapy for patients with type 2 diabetes.
    Garber AJ
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():1-5. PubMed ID: 19817776
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
    Kirby M
    Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quality of diabetes care in Norwegian general practice].
    Claudi T; Ingskog W; Cooper JG; Jenum AK; Hausken MF
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2570-4. PubMed ID: 19023353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin therapy for type 2 diabetes. Getting started.
    Snyder C; Hirsch IB
    Diabetes Self Manag; 2008; 25(4):30, 32-3, 35-6. PubMed ID: 18717025
    [No Abstract]   [Full Text] [Related]  

  • 9. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classic drug in diabetes therapy. Revise contraindications?].
    Aumiller J
    MMW Fortschr Med; 2007 May; 149(22):14. PubMed ID: 18074455
    [No Abstract]   [Full Text] [Related]  

  • 11. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ; White RD
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating innovative tools into the management of type 2 diabetes to improve patient self-management.
    Kruger DF
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():17-20. PubMed ID: 19402256
    [No Abstract]   [Full Text] [Related]  

  • 14. Appropriate advancement of type 2 diabetes therapy.
    Meneghini L; Kennedy L; Koff R; Kuritzky L; Leal S; Peterson K; Zamudio V
    J Fam Pract; 2007 Oct; 56(10 Suppl A):19A-29A; quiz 30A. PubMed ID: 17949601
    [No Abstract]   [Full Text] [Related]  

  • 15. [Optimal therapeutic strategy in type 2 diabetes mellitus].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
    [No Abstract]   [Full Text] [Related]  

  • 16. U-500 concentrated regular insulin: practical application in the outpatient setting.
    Taylor S
    Nurse Pract; 2012 Sep; 37(9):47-52. PubMed ID: 22922723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
    Yeap BB
    Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
    Rave K; Heise T; Pfützner A; Boss AH
    Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin requirement after one year of insulin therapy in type 2 diabetic patients dependent on fasting C-peptide.
    Biesenbach G; Bodlaj G; Pieringer H; Raml A
    Neth J Med; 2008 Jun; 66(6):259-60. PubMed ID: 18689911
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.